AngioDefender® Technology Benefits for your Practice

Change the Way you Administer Care

What if you could predict CVD in patients before symptoms appear?

Medical providers can trust the AngioDefender® device to identify early-stage CVD in asymptomatic patients and evaluate development of atherosclerosis. All of this is possible before performing lab tests or administering expensive or invasive procedures, such as an EKG or angiogram.

Why Use the AngioDefender® device?

Whether you’re focused on primary patient care, wellness, rehabilitation or even corporate wellness, providers and practices can use the AngioDefender® device to deliver better, more preventive patient care.

Improve patient management decisions

Identify early-stage CVD in asymptomatic patients and monitor the effectiveness of prescription therapy and lifestyle modification.

Provide quick, accurate assessments

Non-invasive and easy to use, the test performed by our AngioDefender® device takes less than 8 minutes and delivers accurate, repeatable results.

Save time and money

Though less expensive and invasive, the AngioDefender® technology has proven to be equivalent to other methods of measuring endothelial function including BAUI, digital thermal monitoring and finger plethysmography. Read more about these comparisons.

Encourage repeat visits

Measure your patients’ progress and engage in ongoing, productive conversations about heart health.

Offer a test that others don’t

Attract new, health-conscious patients by being among the first to offer AngioDefender® device testing.

Give Patients Better Control of Heart Health

Many CVD issues are preventable with early detection and the right treatments. With the AngioDefender® technology as an early detection method, the following behavioral and pharmacological interventions have been clinically shown to reduce several CVD risk factors and positively affect endothelial function.CVD Risk Factor Table

Benefits for Providers and Patients

The AngioDefender® technology is effective, accurate and significantly reduces technical, clinical and cost challenges associated with these types of tests.

Providers who already use the AngioDefender® technology say it has improved medical outcomes and reduced healthcare costs — a benefit their patients appreciate. And because it is the most cost-effective way to assess risk in asymptomatic patients, clinics that offer the test attract new and more health-conscious patients.

In addition to medical providers, Everist Health developed the device as a tool that benefits primary care clinics, physical therapy programs, weight loss centers and corporate wellness programs.

View our Provider BrochureClinical Insert Pamphlet OR OUR WHITE PAPER for more info.(pdf)